About Omeros Corp
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.omeros.com/
Frequently Asked Questions
What is the 52-week range for OMER?
The 52-week high is $21.2399 and the 52-week low is $4.06.
What is the P/E ratio for OMER?
The Price to Earnings (P/E) ratio is 10.76.
What is the dividend yield for OMER?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 107.50%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 180.34%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.65.
Analyst Recommendation Trends
Wall Street analyst consensus for OMER over the last few months:
Latest OMER News
This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.
Dow Jones Futures Fall After Nasdaq Hits New High; Sandisk, Micron Trigger Buy Signals
The Nasdaq hit a new high with memory giants Sandisk and Micron flashing buy signals. But financials are struggling.
Dow Jones Futures: Nasdaq Hits New High; Sandisk, Micron Trigger Buy Signals
The Nasdaq hit a new high with memory giants Sandisk and Micron flashing buy signals. But financials are struggling.
NTRA Stock Hits All-Time High, OMER Stock Scales 5-Year Peak – What’s Driving Investors’ Enthusiasm Today?
Natera’s Signatera test secured a key regulatory approval, while Cantor raised its sales expectations for Omeros’ lead drug, Yartemlea.
Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst
Cantor upgrades Omeros to Overweight with a $22 price forecast following strong Yartemlea sales and Medicare reimbursement momentum.
On Holding, Viking Therapeutics, Shopify And Other Big Stocks Moving Higher On Tuesday
U.S. stocks rose, led by On Holding's 13% surge after strong guidance and a $1B buyback; Viking Therapeutics and others also gained.
This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Analysts upgraded MetLife, Brinker, Plexus, West Pharma and Omeros, raising ratings and price targets.
Cantor Fitzgerald Upgrades Omeros to Overweight, Announces $22 Price Target
Cantor Fitzgerald analyst Olivia Brayer Saunders upgrades Omeros (NASDAQ:OMER) from Neutral to Overweight and announces $22 price target.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-23 | Borges David J. | -10,000 | - | - |
| 2026-09-23 | Borges David J. | -10,000 | $20.95 | $209,500 |
| 2026-09-23 | Borges David J. | +10,000 | $15.58 | $155,800 |
| 2026-09-22 | Borges David J. | -5,000 | - | - |
| 2026-09-22 | Borges David J. | -5,000 | - | - |
| 2026-09-22 | Borges David J. | -10,000 | $20.95 | $209,500 |
| 2026-09-22 | Borges David J. | +5,000 | $2.94 | $14,700 |
| 2026-09-22 | Borges David J. | +5,000 | $3.93 | $19,650 |
| 2026-08-31 | Cancelmo Peter B | -25,000 | - | - |
| 2026-08-31 | Cancelmo Peter B | -25,000 | $18.5416 | $463,540 |
| 2026-08-31 | Cancelmo Peter B | +25,000 | $2.94 | $73,500 |
| 2026-08-28 | Cancelmo Peter B | -25,000 | - | - |
| 2026-08-28 | Cancelmo Peter B | -25,000 | $18.6451 | $466,128 |
| 2026-08-28 | Cancelmo Peter B | +25,000 | $2.94 | $73,500 |
| 2026-08-27 | HANISH ARNOLD C | -7,500 | - | - |
| 2026-08-27 | HANISH ARNOLD C | -2,500 | - | - |
| 2026-08-27 | HANISH ARNOLD C | -5,000 | $19.0161 | $95,081 |
| 2026-08-27 | HANISH ARNOLD C | -5,000 | $18.8762 | $94,381 |
| 2026-08-27 | HANISH ARNOLD C | +7,500 | $14.66 | $109,950 |
| 2026-08-27 | HANISH ARNOLD C | +2,500 | $15.81 | $39,525 |
| 2026-08-26 | HANISH ARNOLD C | -5,000 | - | - |
| 2026-08-26 | HANISH ARNOLD C | -5,000 | $18.5265 | $92,633 |
| 2026-08-26 | HANISH ARNOLD C | +5,000 | $15.81 | $79,050 |
| 2026-08-24 | Borges David J. | -906 | - | - |
| 2026-08-24 | Borges David J. | -906 | $19.1 | $17,305 |
| 2026-08-24 | Borges David J. | +906 | $2.94 | $2,664 |
| 2026-08-21 | Borges David J. | -4,094 | - | - |
| 2026-08-21 | Borges David J. | -5,906 | - | - |
| 2026-08-21 | Borges David J. | -10,000 | $18.95 | $189,500 |
| 2026-08-21 | Borges David J. | +4,094 | $2.94 | $12,036 |
| 2026-08-21 | Borges David J. | +5,906 | $3.93 | $23,211 |
| 2026-08-20 | Cable Thomas J. | -7,500 | - | - |
| 2026-08-20 | Cable Thomas J. | -7,500 | - | - |
| 2026-08-20 | Cable Thomas J. | -15,000 | $18.4515 | $276,773 |
| 2026-08-20 | Cable Thomas J. | +7,500 | $3.93 | $29,475 |
| 2026-08-20 | Cable Thomas J. | +7,500 | $2 | $15,000 |
| 2026-08-13 | Borges David J. | -5,000 | - | - |
| 2026-08-13 | Borges David J. | -5,000 | $16.95 | $84,750 |
| 2026-08-13 | Borges David J. | +5,000 | $3.93 | $19,650 |
| 2026-08-12 | Schocken Joseph L | +30,000 | - | - |
| 2026-07-22 | Demopulos Gregory A MD | +1,000,000 | - | - |
| 2026-07-22 | Cancelmo Peter B | +105,000 | - | - |
| 2026-07-22 | Borges David J. | +105,000 | - | - |
| 2026-06-18 | Shah Rajiv | +15,000 | - | - |
| 2026-06-18 | Perkinson Diana T. | +15,000 | - | - |
| 2026-06-18 | Hood Leroy E. MD PhD | +15,000 | - | - |
| 2026-06-18 | Demopulos Peter A MD | +15,000 | - | - |
| 2026-06-18 | Cable Thomas J. | +15,000 | - | - |
| 2026-06-18 | Bumol Thomas F. | +15,000 | - | - |
| 2026-06-18 | HANISH ARNOLD C | +15,000 | - | - |
| 2026-05-22 | Cable Thomas J. | -7,500 | - | - |
| 2026-05-22 | Cable Thomas J. | -7,500 | $11.6052 | $87,039 |
| 2026-05-22 | Cable Thomas J. | +7,500 | $10.84 | $81,300 |
| 2026-02-18 | Demopulos Gregory A MD | -400,000 | - | - |
| 2026-02-18 | Demopulos Gregory A MD | -357,678 | $11.93 | $4,267,099 |
| 2026-02-18 | Demopulos Gregory A MD | +400,000 | $10.27 | $4,108,000 |
| 2026-01-13 | Borges David J. | -30,000 | - | - |
| 2026-01-13 | Borges David J. | -30,000 | $12.3105 | $369,315 |
| 2026-01-13 | Borges David J. | +30,000 | $3.06 | $91,800 |
| 2026-01-12 | Borges David J. | -30,000 | $12.72 | $381,600 |
| 2025-10-13 | Demopulos Gregory A MD | +300,000 | - | - |
| 2025-10-13 | Demopulos Gregory A MD | +300,000 | - | - |
| 2025-10-13 | Demopulos Gregory A MD | -600,000 | - | - |